Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection

AIMS: The aim is to evaluate the efficacy and safety of Sofosbuvir- (SOF-) based direct-acting antiviral agents (DAAs) treatment for patients with genotype (GT) 3/6 hepatitis C virus (HCV) infection. METHODS: Patients infected with GT 3/6 HCV and treated with SOF-based DAAs were enrolled in this pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Yong-yu, Chen, You-ming, Wu, Yuan-kai, Zhang, Xiao-hong, Xu, Wen-xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648714/
https://www.ncbi.nlm.nih.gov/pubmed/33194875
http://dx.doi.org/10.1155/2020/8872120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648714/
https://www.ncbi.nlm.nih.gov/pubmed/33194875
http://dx.doi.org/10.1155/2020/8872120

Ejemplares similares